Skip to main content
. Author manuscript; available in PMC: 2013 Jul 25.
Published in final edited form as: Ann Intern Med. 2012 Aug 21;157(4):242–250. doi: 10.7326/0003-4819-157-4-201208210-00004

Table 1.

Risk Factor Distributions and Estimated Model Coefficients From the LLP Case–Control Data*

Variable Case Patients, n (%) Control Participants, n (%) Odds Ratio (95% CI) Model Coefficient
Full Model Reduced Model
Risk factor
  Smoking duration

    Never 25 (5.9) 240 (28.3) 1.00 (reference)

    1–19 y 37 (8.7) 171 (20.2) 2.17 (1.21–3.85) 0.769 0.795

    20–39 y 122 (28.6) 249 (29.4) 4.27 (2.62–6.94) 1.452 1.470

    40–59 y 227 (53.2) 176 (20.8) 12.27 (7.41–20.30) 2.507 2.536

    ≥60 y 16 (3.8) 12 (1.4) 15.25 (5.71–40.65) 2.724 2.742

  History of pneumonia 97 (22.7) 129 (15.2) 1.83 (1.26–2.64) 0.602 0.592

  Asbestos exposure 150 (35.1) 202 (23.8) 1.89 (1.35–2.62) 0.634

  History of cancer 60 (14.1) 59 (7.0) 1.96 (1.22–3.14) 0.675 0.680
  Family history of lung cancer

    None 314 (73.5) 699 (82.4) 1.00 (reference)

    Early onset (age <60 y) 44 (10.3) 40 (4.7) 2.02 (1.18–3.45) 0.703 0.690

    Late onset (age ≥60 y) 69 (16.2) 109 (12.9) 1.18 (0.79–1.76) 0.168 0.201

Internal validation
  AUC 0.758 0.753

AUC = area under the receiver-operating characteristic curve; LLP = Liverpool Lung Project.

*

Table adapted from reference 12.

Excludes asbestos exposure.